We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Sep 2021
  • Code : CMI4626
  • Pages : 243
  • Formats :
      Excel/PDF
  • Industry : Pharmaceutical

Pain management is a broad branch of medical science that utilizes an interdisciplinary approach to easing the patient's suffering and enhancing the quality of life of patients with chronic pain. A common aim of pain management is reducing the use of narcotics or pain killers, relaxing the patients' lifestyle and providing education on stress and pain management. The use of pain management treatments in combination with a holistic approach to disease prevention and therapy is now recognized as an effective treatment approach for moderate to severe pain. Chronic pain can result from injury, disease or injury, or be the result of a disease such as cancer or Parkinson's disease.

Market Dynamics:

R&D of new therapeutics is expected to propel growth of the global pain management therapeutics market over the forecast period. For instance, in August 2021, Flexion Therapeutics, Inc. expanded the placebo-controlled trial of FX301, a novel formulation of a locally administered NaV1.7 inhibitor (funapide) which aims to provide at least three to five days of post-operative pain relief while preserving motor function, in patients undergoing bunionectomy.

Moreover, increasing number of pain management clinics is also expected to aid in growth of the market. For instance, in August 2021, QC Kinetix, a regenerative medicine company that offers a non-surgical alternative to pain relief, started a new location Birmingham.

Key features of the study:

  • This report provides in-depth analysis of the global pain management therapeutics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pain management therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AcelRx Pharmaceuticals, Inc. Averitas Pharma, Inc., AmerisourceBergen, Cardinal Health, McKesson Corporation, Johnson & Johnson, Teva Pharmaceuticals, Abbott Laboratories, Allergan, Inc., Covidien plc, Durect Corporation, Eli Lilly and Company, Endo Health Solutions, Inc., Forest Laboratories, Inc., GlaxoSmithKline plc, Hospira, Inc., Merck & Co., Inc., Mundipharma International Ltd., and Novartis  International AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management therapeutics market

Detailed Segmentation:

  •  Global Pain Management Therapeutics Market, By Pain Type:
    • Chronic
    • Acute
  • Global Pain Management Therapeutics Market, By Drug Class:
    • NSAIDS
    • Anesthetics
  • Global Pain Management Therapeutics Market, By Region:
    • North America
      • By Pain Type
        • Chronic
        • Acute
      • By Drug Class
        • NSAIDS
        • Anesthetics
        • Anticonvulsant
        • Anti-migraine Drugs
        • Antidepressant Drugs
        • Opioids
        • Non-narcotics
        • Analgesics
      • By Indication
        • Arthritic Pain
        • Neuropathic Pain
        • Cancer Pain
        • Chronic Pain
        • Post-operative Pain
        • Migraine
        • Fibromyalgia
        • Bone Fracture
        • Muscle Sprain/Strain
        • Acute Appendicitis
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Pain Type
        • Chronic
        • Acute
      • By Drug Class
        • NSAIDS
        • Anesthetics
        • Anticonvulsant
        • Anti-migraine Drugs
        • Antidepressant Drugs
        • Opioids
        • Non-narcotics
        • Analgesics
      • By Indication
        • Arthritic Pain
        • Neuropathic Pain
        • Cancer Pain
        • Chronic Pain
        • Post-operative Pain
        • Migraine
        • Fibromyalgia
        • Bone Fracture
        • Muscle Sprain/Strain
        • Acute Appendicitis
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Pain Type
        • Chronic
        • Acute
      • By Drug Class
        • NSAIDS
        • Anesthetics
        • Anticonvulsant
        • Anti-migraine Drugs
        • Antidepressant Drugs
        • Opioids
        • Non-narcotics
        • Analgesics
      • By Indication
        • Arthritic Pain
        • Neuropathic Pain
        • Cancer Pain
        • Chronic Pain
        • Post-operative Pain
        • Migraine
        • Fibromyalgia
        • Bone Fracture
        • Muscle Sprain/Strain
        • Acute Appendicitis
        • Others
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Pain Type
        • Chronic
        • Acute
      • By Drug Class
        • NSAIDS
        • Anesthetics
        • Anticonvulsant
        • Anti-migraine Drugs
        • Antidepressant Drugs
        • Opioids
        • Non-narcotics
        • Analgesics
      • By Indication
        • Arthritic Pain
        • Neuropathic Pain
        • Cancer Pain
        • Chronic Pain
        • Post-operative Pain
        • Migraine
        • Fibromyalgia
        • Bone Fracture
        • Muscle Sprain/Strain
        • Acute Appendicitis
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Pain Type
        • Chronic
        • Acute
      • By Drug Class
        • NSAIDS
        • Anesthetics
        • Anticonvulsant
        • Anti-migraine Drugs
        • Antidepressant Drugs
        • Opioids
        • Non-narcotics
        • Analgesics
      • By Indication
        • Arthritic Pain
        • Neuropathic Pain
        • Cancer Pain
        • Chronic Pain
        • Post-operative Pain
        • Migraine
        • Fibromyalgia
        • Bone Fracture
        • Muscle Sprain/Strain
        • Acute Appendicitis
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Pain Type
        • Chronic
        • Acute
      • By Drug Class
        • NSAIDS
        • Anesthetics
        • Anticonvulsant
        • Anti-migraine Drugs
        • Antidepressant Drugs
        • Opioids
        • Non-narcotics
        • Analgesics
      • By Indication
        • Arthritic Pain
        • Neuropathic Pain
        • Cancer Pain
        • Chronic Pain
        • Post-operative Pain
        • Migraine
        • Fibromyalgia
        • Bone Fracture
        • Muscle Sprain/Strain
        • Acute Appendicitis
        • Others
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • AcelRx Pharmaceuticals, Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Averitas Pharma, Inc.
    • AmerisourceBergen
    • Cardinal Health
    • McKesson Corporation
    • Johnson & Johnson
    • Teva Pharmaceuticals
    • Abbott Laboratories
    • Allergan, Inc
    • Covidien plc
    • Durect Corporation
    • Eli Lilly and Company
    • Endo Health Solutions, Inc
    • Forest Laboratories, Inc.
    • GlaxoSmithKline plc
    • Hospira, Inc.
    • Merck & Co., Inc
    • Mundipharma International Ltd.
    • Novartis International AG

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Pain Type
      • Market Snippet, By Drug Class
      • Market Snippet, By Indication
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • Regulatory Scenario
    • PEST Analysis
    • Mergers and Acquisitions
  4. Global Pain Management Therapeutics Market, By Pain Type, 2020 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Chronic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Acute
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
  5. Global Pain Management Therapeutics Market, By Drug Class, 2020 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • NSAIDS
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Anesthetics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Anticonvulsant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Anti-migraine Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Antidepressant Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Opioids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Non-narcotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
  6. Global Pain Management Therapeutics Market, By Indication, 2020 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Arthritic Pain
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Neuropathic Pain
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Cancer Pain
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Chronic Pain
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Post-operative Pain
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Migraine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Fibromyalgia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Bone Fracture
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Muscle Sprain/Strain
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Acute Appendicitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
  7. Global Pain Management Therapeutics Market, By Region, 2020 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018–2028
    • North America
      • Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Pain Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Drug Class, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Indication, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Company Profiles
      • AcelRx Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Averitas Pharma, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AmerisourceBergen
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cardinal Health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • McKesson Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Teva Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Allergan, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Covidien plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Durect Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Endo Health Solutions, Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Forest Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GlaxoSmithKline plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hospira, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mundipharma International Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis  International AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 34 figures on “Pain Management Therapeutics Market - Global forecast to 2028”.

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.